Events

Videos

Podcasts

Articles

Clinical

® Clinical Focus page includes a listing of all specialities covered across  OncLive.com, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, hematologic malignancies, and gynecologic cancers. Each individual specialty page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances in both the localized and metastatic settings, and ongoing research.


DLBCL Risk Assessment and Genetic Signatures

Tolerability of Triplet Therapy in Multiple Myeloma

Therapy Initiation Prior to Cytogenetic Testing Results

Frontline Triplet Therapies in Multiple Myeloma

Advances of chimeric antigen receptor T-cell therapy technologies are in rapid development and under investigation in a range of preclinical and clinical research around the globe.

CAR T Pioneers Describe Challenges Faced in Cancer

Naval G. Daver, MD, discusses the advancing treatment landscape in both acute myeloid leukemia and acute lymphoblastic leukemia.

Dr. Daver on the Advancing Treatment Landscape in AML 

Naval G. Daver, MD, discusses the utility of maintenance chemotherapy in acute myeloid leukemia.



Dr. Daver on the Utility of Maintenance Therapy in AML

Closing Thoughts on Treatment of R/R DLBCL

Improving Outcomes in Patients With R/R DLBCL

Emerging Therapies for R/R DLBCL

Safety and Efficacy of Oral Agents in R/R DLBCL

Treatment of R/R DLBCL: CD19-Directed Therapy vs CAR T

CD19-Directed Therapies for Treatment of R/R DLBCL

CAR T in R/R DLBCL: Safety and Patient Selection

ASCO 2020 Data: CAR T in R/R DLBCL

Role of CAR T-cell Therapy in R/R DLBCL

Treatment in Transplant-ineligible R/R DLBCL

Prognosis of R/R DLBCL

Standard of Care for Treatment of DLBCL

David Sallman, MD, discusses the combination of eprenetapopt and azacitidine, a new standard of care for patients with myelodysplastic syndromes with a susceptible TP53 mutation. 

Phase 3 Data With Eprenetapopt Plus Azacitidine Anticipated in High-Risk MDS/AML

Chronic Lymphocytic Leukemia

 Chronic Lymphocytic Leukemia condition center page is a comprehensive resource for clinical news and expert insights on treatment advances and ongoing research in chronic lymphocytic leukemia. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs and updates with chronic lymphocytic leukemia therapy. 

Non-Hodgkin Lymphoma

The OncLive Non-Hodgkin Lymphoma condition center page is a comprehensive resource for clinical news and expert insights on various types of non-Hodgkin lymphoma, including diffuse large B-cell lymphoma, follicular lymphoma, chronic lymphocytic leukemia, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in non-Hodgkin lymphoma.

Mantle Cell Lymphoma

The OncLive Mantle Cell Lymphoma condition center page is a comprehensive resource for clinical news and expert insights on mantle cell lymphoma treatment.  This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, therapeutic advances, and ongoing research in mantle cell lymphoma.

Multiple Myeloma

The OncLive Multiple Myeloma condition center page is a comprehensive resource for clinical news and expert insights on multiple myeloma and how to treat patients with monoclonal antibodies, proteasome inhibitors, bispecific T-cell engagers, immunomodulatory agents, CAR T-cell therapy, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in multiple myeloma.

Myeloproliferative Neoplasms

The OncLive Myeloproliferative Neoplasms condition center is a comprehensive resource for clinical news and expert insights on myeloproliferative neoplasms, including myelofibrosis, polycythemia vera, and essential thrombocythemia. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in myeloproliferative neoplasms.

The OncLive Hematology Oncology condition center page is a comprehensive resource for clinical news and expert insights on various hematologic malignancies, including leukemias, lymphomas, myeloproliferative neoplasms, multiple myeloma, and much more. This section features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in hematologic cancers.

Hematologic Oncology | Specialty